BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22113338)

  • 1. Multi-platform data integration in microarray analysis.
    Tsiliki G; Zervakis M; Ioannou M; Sanidas E; Stathopoulos E; Potamias G; Tsiknakis M; Kafetzopoulos D
    IEEE Trans Inf Technol Biomed; 2011 Nov; 15(6):806-12. PubMed ID: 22113338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixture classification model based on clinical markers for breast cancer prognosis.
    Zeng T; Liu J
    Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A GMM-IG framework for selecting genes as expression panel biomarkers.
    Wang M; Chen JY
    Artif Intell Med; 2010; 48(2-3):75-82. PubMed ID: 20004087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-platform comparison and visualisation of gene expression data using co-inertia analysis.
    Culhane AC; Perrière G; Higgins DG
    BMC Bioinformatics; 2003 Nov; 4():59. PubMed ID: 14633289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data.
    Xu L; Tan AC; Naiman DQ; Geman D; Winslow RL
    Bioinformatics; 2005 Oct; 21(20):3905-11. PubMed ID: 16131522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.
    Gruvberger S; Ringnér M; Chen Y; Panavally S; Saal LH; Borg A ; Fernö M; Peterson C; Meltzer PS
    Cancer Res; 2001 Aug; 61(16):5979-84. PubMed ID: 11507038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting features of breast cancer with gene expression patterns.
    Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
    Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
    Lancashire LJ; Rees RC; Ball GR
    Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.
    Yu K; Ganesan K; Miller LD; Tan P
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3288-96. PubMed ID: 16740749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiles of the oestrogen receptor in breast cancer.
    Kok M; Linn SC
    Neth J Med; 2010 Oct; 68(10):291-302. PubMed ID: 21071774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
    Györffy B; Lanczky A; Eklund AC; Denkert C; Budczies J; Li Q; Szallasi Z
    Breast Cancer Res Treat; 2010 Oct; 123(3):725-31. PubMed ID: 20020197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new multiple regression approach for the construction of genetic regulatory networks.
    Zhang SQ; Ching WK; Tsing NK; Leung HY; Guo D
    Artif Intell Med; 2010; 48(2-3):153-60. PubMed ID: 19963359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classification of microarray data with factor mixture models.
    Martella F
    Bioinformatics; 2006 Jan; 22(2):202-8. PubMed ID: 16287938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural networks.
    Yang ZR
    Methods Mol Biol; 2010; 609():197-222. PubMed ID: 20221921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical analysis of an RNA titration series evaluates microarray precision and sensitivity on a whole-array basis.
    Holloway AJ; Oshlack A; Diyagama DS; Bowtell DD; Smyth GK
    BMC Bioinformatics; 2006 Nov; 7():511. PubMed ID: 17118209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integration of gene signatures using biological knowledge.
    Blazadonakis ME; Zervakis ME; Kafetzopoulos D
    Artif Intell Med; 2011 Sep; 53(1):57-71. PubMed ID: 21767937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limits of predictive models using microarray data for breast cancer clinical treatment outcome.
    Reid JF; Lusa L; De Cecco L; Coradini D; Veneroni S; Daidone MG; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2005 Jun; 97(12):927-30. PubMed ID: 15956654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A hierarchical Naïve Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarrays.
    Demichelis F; Magni P; Piergiorgi P; Rubin MA; Bellazzi R
    BMC Bioinformatics; 2006 Nov; 7():514. PubMed ID: 17125514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential patterns mining and gene sequence visualization to discover novelty from microarray data.
    Sallaberry A; Pecheur N; Bringay S; Roche M; Teisseire M
    J Biomed Inform; 2011 Oct; 44(5):760-74. PubMed ID: 21527357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.